Milestone Achievement - Completion of 100 MRgFUS Treatments

Exablate Neuro is changing neurosurgery by offering an incision-less treatment option for essential tremor and tremor-dominant Parkinson's disease patients. MRgFUS is a non-invasive therapeutic technology that combines MRI imaging to precisely target and treat various medical conditions with focused ultrasound waves that ablate deep brain targets with no surgical incisions. 

Royal Care Hospital in Coimbatore has completed 100 treatments using Magnetic Resonance-guided Focused Ultrasound (MRgFUS), marking a significant milestone in its medical services. The achievement of completing 100 MRgFUS treatments at Royal Care Hospital highlights the institution's leadership in adopting innovative medical technologies and its commitment to improving patient treatment. This milestone is a significant step forward in the hospital's mission to provide top-quality healthcare services.

DSS Imagetech Pvt. Ltd. a renowned medical distributor company, being the authorized distributor of Insightech in the South East region of the Continent has been working very closely with Royal Care Hospital since October 2021 when the machine was installed. We at DSS are confident that we will establish many more treatment centers in India, helping patients and their loved ones suffer less from Parkinson & Essential tremors and contributing to a tremor-free, happier nation.

Key Highlights:

• Patient Benefits: The completion of 100 MRgFUS treatments underscores the hospital's commitment to patient care and innovation. Patients benefit from reduced recovery times, minimal discomfort, and the avoidance of surgical risks associated with traditional procedures.
• Expertise and Precision: The successful treatments reflect the expertise of Royal Care Hospital's medical team and their proficiency in using this advanced technology. The precision of MRgFUS allows for targeted treatment with minimal impact on surrounding healthy tissues.
• Patient Testimonials: Numerous patients have reported significant improvements in their conditions following MRgFUS treatment at Royal Care Hospital. Testimonials highlight the positive outcomes and enhanced quality of life experienced by patients undergoing this state-of-the-art treatment.
• Future Prospects: Royal Care Hospital continues to lead in the adoption of innovative medical technologies. The milestone of 100 MRgFUS treatments sets the stage for future advancements and the potential to treat a broader range of conditions using this technology.